ArticleOphthalmology science
Advancing Glaucoma Diagnosis: Employing Confidence-Calibrated Label Smoothing Loss for Model Calibration.
Article in Ophthalmology science. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A Hierarchical Deep Learning Architecture for Diagnosing Retinal Diseases Using Cross-Modal OCT to Fundus Translation in the Lack of Paired Data.Journal of imaging · 2026Article
- Beyond convolutions and supervised learning with transformers and representation learning for retinal image analysis.Progress in retinal and eye research · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The aim of our research is to enhance the calibration of machine learning models for glaucoma classification through a specialized loss function named Confidence-Calibrated Label Smoothing (CC-LS) loss. This approach is specifically designed to refine model calibration without compromising accuracy by integrating label smoothing and confidence penalty techniques, tailored to the specifics of glaucoma detection. Design: This study focuses on the development and evaluation of a calibrated deep learning model. Participants: The study employs fundus images from both external datasets-the Online Retinal Fundus Image Database for Glaucoma Analysis and Research (482 normal, 168 glaucoma) and the Retinal Fundus Glaucoma Challenge (720 normal, 80 glaucoma)-and an extensive internal dataset (4639 images per category), aiming to bolster the model's generalizability. The model's clinical performance is validated using a comprehensive test set (47 913 normal, 1629 glaucoma) from the internal dataset. Methods: The CC-LS loss function seamlessly integrates label smoothing, which tempers extreme predictions to avoid overfitting, with confidence-based penalties. These penalties deter the model from expressing undue confidence in incorrect classifications. Our study aims at training models using the CC-LS and comparing their performance with those trained using conventional loss functions. Main Outcome Measures: The model's precision is evaluated using metrics like the Brier score, sensitivity, specificity, and the false positive rate, alongside qualitative heatmap analyses for a holistic accuracy assessment. Results: Preliminary findings reveal that models employing the CC-LS mechanism exhibit superior calibration metrics, as evidenced by a Brier score of 0.098, along with notable accuracy measures: sensitivity of 81%, specificity of 80%, and weighted accuracy of 80%. Importantly, these enhancements in calibration are achieved without sacrificing classification accuracy. Conclusions: The CC-LS loss function presents a significant advancement in the pursuit of deploying machine learning models for glaucoma diagnosis. By improving calibration, the CC-LS ensures that clinicians can interpret and trust the predictive probabilities, making artificial intelligence-driven diagnostic tools more clinically viable. From a clinical standpoint, this heightened trust and interpretability can potentially lead to more timely and appropriate interventions, thereby optimizing patient outcomes and safety. Financial Disclosures: Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.